Safer viruses for vaccine research and diagnosis
The researchers have effectively developed a new biotechnology platform requiring low biocontainment, to help safely develop vaccines and diagnostics against a mosquito-borne diseases.
24 Jan 2020 ⋅ Science Translational Medicine
From the ‘valley of death’ to supply and demand sustainability – the unfinished agenda for immunisation
The article describes four hurdles that must be overcome to ensure sustainable impact. It also highlights actions required to achieve 'the full potential of immunisation for human health and society'.
6 Nov 2019 ⋅ Nature
Lassa virus’ soft spot revealed
Detailed structural studies provide blueprint for the development of potent therapeutics and vaccines.
8 Aug 2019 ⋅ Cell
Thermally-stable TB vaccine closer to reality thanks to microscopic silica cages
A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
8 Aug 2019 ⋅ Scientific Reports
Measles vaccination: ‘All for one and one for all’
A specter of clinical, ethical, public health and legal concerns have been raised by recent outbreaks, including the freedom of a parent to choose not to vaccinate.
24 May 2019 ⋅ American Journal of Medicine